NanoViricides
NNVC
#10132
Rank
A$33.5 M
Marketcap
A$1.86
Share price
0.82%
Change (1 day)
-17.75%
Change (1 year)

NanoViricides (NNVC) - Total assets

Total assets on the balance sheet as of June 2025 : A$13.35 Million

According to NanoViricides's latest financial reports the company's total assets are A$13.35 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

NanoViricides - Total assets on balance sheet (from 2006 to 2025)

Total assets by year

Year Total assets Change
2024-06-30A$19.21 M-24.24%
2023-06-30A$25.35 M-25.55%
2022-06-30A$34.06 M-15.61%
2021-06-30A$40.36 M16.49%
2020-06-30A$34.64 M80.95%
2019-06-30A$19.14 M-23.57%
2018-06-30A$25.05 M-28.77%
2017-06-30A$35.17 M-28.49%
2016-06-30A$49.18 M-14.36%
2015-06-30A$57.42 M23.47%
2014-06-30A$46.51 M158.8%
2013-06-30A$17.97 M17.78%
2012-06-30A$15.26 M52.03%
2011-06-30A$10.03 M-5.45%
2010-06-30A$10.61 M186.17%
2009-06-30A$3.7 M141.65%
2008-06-30A$1.53 M-3.73%
2007-06-30A$1.59 M-56.79%
2006-06-30A$3.69 M
2005-06-30N/A

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
BioCryst Pharmaceuticals
BCRX
A$0.67 B 4,959.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.78 B 13,271.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$88.60 B 663,232.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$146.65 B 1,097,906.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$196.09 B 1,467,996.39%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.81 B 934,392.89%๐Ÿ‡ฌ๐Ÿ‡ง UK